
|Articles|January 29, 2016
Hep C, Melanoma Drug Approvals Highlight Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/hep-c-melanoma-drug-approvals-highlight-week-in-sp" target="_blank">View the story "Hep C, Melanoma Drug Approvals Highlight Week in Specialty Pharmacy" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
Population Genomic Screening Improves Lipid Management in Familial Hypercholesterolemia
5













































































































































































































